Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001062993-25-005834
Filing Date
2025-03-18
Accepted
2025-03-18 19:18:19
Documents
1
Period of Report
2025-03-11

Document Format Files

Seq Description Document Type Size
1 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4a.html 4/A  
1 AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4a.xml 4/A 4119
  Complete submission text file 0001062993-25-005834.txt   5691
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Issuer) CIK: 0001267565 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 780 DEDHAM STREET, SUITE 800 CANTON MA 02021
Business Address
Dreyer Scott (Reporting) CIK: 0001746251 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37372 | Film No.: 25750304